Dec 15, 2014 02:51 PM EST
German drugmakers including Stada, Torrent's Heumann and Dr. Reddy's betapharm have appealed a regulator's decision to suspend approval of some drugs over concerns about clinical trials conducted by an Indian company.
Regulators in France, Germany, Belgium and Luxembourg this month suspended marketing approval for 25 drugs over the quality of trial data from India's GVK Biosciences.
Companies that have filed an appeal will be allowed to resume sales of affected products until their appeals are either approved or struck down, Germany's Federal Institute for Drugs and Medical Devices (BfArM) said on Monday.
"We are reviewing the appeals thoroughly and quickly," a spokesman for BfArM said.
The regulator last week had published a list of 80 affected products that their manufacturers would not be allowed to sell until they had provided new clinical data.
2. Jul 31, 2018
Pair of colliding stars spill radioactive molecules into space
3. Jul 27, 2018
Targeting headaches and tumors with nano-submarines
4. Jul 26, 2018
Researchers develop a new method to detect nucleation
3. Jul 24, 2018
Researchers unravel more mysteries of metallic hydrogen
4. Sep 11, 2017
E-cigarettes Containing Nicotine Increase Arterial Stiffness, Heart Rate & Blood Pressure